| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Department of Biochemistry, University of Texas Health Science Center, Tyler, TX 75708; and
Complement Research Unit, Haartman Institute, University of Helsinki, Helsinki, Finland
In the alternative pathway of complement (APC) factor H is the primary control factor involved in discrimination between potential pathogens. The APC deposits C3b on possible Ags, and the interaction with factor H determines whether the initial C3b activates the APC. Factor H is composed of a linear array of 20 homologous short consensus repeats (SCR) domains with many functional sites. Three of these sites are involved in binding C3b and regulating complement activation; others bind to sialic acid and/or heparin and are responsible for host recognition. Using site-directed mutations we have examined the contributions of each of these sites to target discrimination and to functional activities of factor H. Decay acceleration by SCR1–4 of C3/C5 convertases bound to nonactivators was strongly dependent on SCR domains 11–15 and 16–20. Loss of these regions caused a 97% loss of activity, with SCR16–20 being the most critical (>90% loss). On APC activators the pattern of site usage was different and unique on each. On yeast, deletion of the 10 C-terminal domains (SCR11–20) had no effect on specific activity. On rabbit erythrocytes, this deletion caused loss of 75% of the specific activity. An examination of binding affinity to C3b on the four cell types demonstrated that factor H exhibits a unique pattern of SCR involvement on each cell. The results reveal a complex molecular mechanism of discrimination between microbes and host in this ancient innate defense system and help explain the different rates and intensities of APC activation on different biological particles.
This article has been cited by other articles:
|
|
 |
|
  H. G. Hocking, A. P. Herbert, D. Kavanagh, D. C. Soares, V. P. Ferreira, M. K. Pangburn, D. Uhrin, and P. N. Barlow Structure of the N-terminal Region of Complement Factor H and Conformational Implications of Disease-linked Sequence Variations J. Biol. Chem., April 4, 2008; 283(14): 9475 - 9487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Zaiss, M. J. Cotter, L. R. White, S. A. Clark, N. C. W. Wong, V. M. Holers, J. S. Bartlett, and D. A. Muruve Complement Is an Essential Component of the Immune Response to Adeno-Associated Virus Vectors J. Virol., March 15, 2008; 82(6): 2727 - 2740. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Fenaille, M. Le Mignon, C. Groseil, C. Ramon, S. Riande, L. Siret, and N. Bihoreau Site-specific N-glycan characterization of human complement factor H Glycobiology, September 1, 2007; 17(9): 932 - 944. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Bishop and P. Gagneux Evolution of carbohydrate antigens--microbial forces shaping host glycomes? Glycobiology, May 1, 2007; 17(5): 23R - 34R. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Wazen, C. E. Tye, H. A. Goldberg, G. K. Hunter, C. E. Smith, and A. Nanci In Vivo Functional Analysis of Polyglutamic Acid Domains in Recombinant Bone Sialoprotein J. Histochem. Cytochem., January 1, 2007; 55(1): 35 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. P. Ferreira, A. P. Herbert, H. G. Hocking, P. N. Barlow, and M. K. Pangburn Critical Role of the C-Terminal Domains of Factor H in Regulating Complement Activation at Cell Surfaces J. Immunol., November 1, 2006; 177(9): 6308 - 6316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Singh, J. Mullick, J. Bernet, and A. Sahu Functional Characterization of the Complement Control Protein Homolog of Herpesvirus Saimiri: ARG-118 IS CRITICAL FOR FACTOR I COFACTOR ACTIVITIES J. Biol. Chem., August 11, 2006; 281(32): 23119 - 23128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Alexander, O.G.B. Aneziokoro, A. Chang, B. K. Hack, A. Markaryan, A. Jacob, R. Luo, M. Thirman, M. Haas, and R. J. Quigg Distinct and Separable Roles of the Complement System in Factor H-Deficient Bone Marrow Chimeric Mice with Immune Complex Disease J. Am. Soc. Nephrol., May 1, 2006; 17(5): 1354 - 1361. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Malakhov, L. M. Aschenbrenner, D. F. Smee, M. K. Wandersee, R. W. Sidwell, L. V. Gubareva, V. P. Mishin, F. G. Hayden, D. H. Kim, A. Ing, et al. Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection. Antimicrob. Agents Chemother., April 1, 2006; 50(4): 1470 - 1479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Thurman and V. M. Holers The Central Role of the Alternative Complement Pathway in Human Disease J. Immunol., February 1, 2006; 176(3): 1305 - 1310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Mullick, J. Bernet, Y. Panse, S. Hallihosur, A. K. Singh, and A. Sahu Identification of Complement Regulatory Domains in Vaccinia Virus Complement Control Protein J. Virol., October 1, 2005; 79(19): 12382 - 12393. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Dave, S. Carmicle, S. Hammerschmidt, M. K. Pangburn, and L. S. McDaniel Dual Roles of PspC, a Surface Protein of Streptococcus pneumoniae, in Binding Human Secretory IgA and Factor H J. Immunol., July 1, 2004; 173(1): 471 - 477. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. K. Ganesh, S. A. Smith, G. J. Kotwal, and K. H. M. Murthy Structure of vaccinia complement protein in complex with heparin and potential implications for complement regulation PNAS, June 15, 2004; 101(24): 8924 - 8929. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Pandiripally, E. Gregory, and D. Cue Acquisition of Regulators of Complement Activation by Streptococcus pyogenes Serotype M1 Infect. Immun., November 1, 2002; 70(11): 6206 - 6214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Pangburn Cutting Edge: Localization of the Host Recognition Functions of Complement Factor H at the Carboxyl-Terminal: Implications for Hemolytic Uremic Syndrome J. Immunol., November 1, 2002; 169(9): 4702 - 4706. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
